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Abstract

Numerous reports indicate that African Americans and Latinos are being affected disproportionately by
coronavirus disease 2019 (COVID-19). Positivity rates have not been analyzed on scale because only 4 states
report race/ethnicity as part of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing. Previous studies also have had little ability to control for many known risk factors to better identify the effects of
COVID-19 on racial and ethnic communities. Using test results from a large national reference laboratory
database that included patients from all 50 states and the District of Columbia, this study compared positivity
rates for SARS-CoV-2 nucleic acid amplification tests (NAAT) among various race/ethnicity groups by linking
zip code-based race/ethnicity proportions from US Census data. Analysis of 2,331,175 unique patients tested
March-May 2020 demonstrated an increasing trend in SARS-CoV-2 NAAT positivity across Black nonHispanic community progressive quintiles (from 7.8% to 17.2%, P < 0.0001) and Hispanic community progressive quintiles (from 8.4% to 15.5%, P < 0.0001) and a decreasing trend across White non-Hispanic community
progressive quintiles (from 17.4% to 7.1%, P < 0.0001). These trends in viral ribonucleic acid positivity remained in stratified analyses and in multivariable models that controlled for known risk factors including sex,
population density, and the states initially hardest hit by COVID-19. These findings indicate that communities
with the highest proportions of Black non-Hispanic and Hispanic populations have the highest SARS-CoV-2
NAAT positivity rates, even after controlling for other risk factors. More efforts are needed to mitigate the
increased impact of COVID-19 on both the African American and Hispanic communities.
Keywords: SARS-CoV-2, COVID-19, race, ethnicity
100,000 people was similar among White (22.7), Asian
(24.3), and Latino (24.9) populations.9
As of June 1, 2020, race/ethnicity was included as part
of confirmed positive cases in 47 states and as part of
COVID-19 death reports in 42 states; however, only 4 states
(Delaware, Illinois, Kansas, and Nevada) report race/
ethnicity testing rates,8 making positivity rates based on race
and ethnicity difficult to calculate. Even in states that have
recently reported confirmed cases and deaths by race and
ethnicity (eg, New York), it can be difficult to know the
degree to which these racial divides are affected by large
African American and Hispanic communities in some of
the areas with the most COVID-19 infections (eg, New York
City). Additionally, conflicting outcomes have been reported on the relationship between SARS-CoV-2 nucleic
acid amplification test (NAAT) positivity and race and

Introduction

N

umerous reports support that ethnic minorities are
being affected disproportionately by SARS-CoV-2 infection and COVID-19 disease.1–6 As of June 24, 2020, there
were nearly 2.4 million confirmed cases of COVID-19 in
the United States and 120,000 COVID-19-related deaths.7
In early June, the reported COVID-19 fatality rate was
nearly 2.5 times higher for African Americans than for the
White non-Hispanic population in the states reporting
race/ethnicity data, with some states showing even larger
disparities.8 These findings are based on data analyses from
the American Public Media Research Lab that indicated
non-Hispanic African Americans accounted for 24% of
COVID-19 deaths, despite comprising only 12% of the US
population.9 The same report noted the mortality rate per
1
2
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ethnicity, and most prior reports were based on a relatively
small number of individuals.10
Positivity rates reflect positive test results among only
those people who were tested. Therefore, positivity rates are
greatly affected by the amount of testing and the selection of
individuals tested. Laboratory test positivity rates must be
distinguished from infection and disease rates. Infection
rates reflect who is infected in the population; incidence is
defined by the occurrence of new cases whereas prevalence
is defined as the proportion of cases in the population at a
given time. Positivity rates are an additional useful measurement in population disease assessment as they account
for the rapidly evolving number of patients being tested. To
best understand the specific contribution of SARS-CoV-2
NAAT positivity rates, this study examined differences
among US Census-defined race/ethnicity groups using data
from a large national reference laboratory.
Methods

All SARS-CoV-2 ribonucleic acid (RNA) molecular
testing was performed by Quest Diagnostics using 4 different US Food and Drug Administration Emergency Use
Authorized tests; the Quest Diagnostics laboratorydeveloped test (Quest SARS-CoV-2 rRT-PCR), the Roche
Diagnostics cobas SARS-CoV-2 test, Hologic Panther Fusion SARS-CoV-2 assay, and Hologic Aptima SARS-CoV-2
test.
Study population

All SARS-CoV-2 NAAT test results performed by Quest
Diagnostics that were stored in the Informatics Data
Warehouse as of June 5, 2020 were retrieved for potential
inclusion in this study. Results were obtained from tests
performed from March 9, 2020 (first day of testing at Quest
Diagnostics) through May 31, 2020. The study population
was limited to 1 result per patient. If any patient SARSCoV-2 NAAT test result was positive, that patient was
considered positive and patients with only negative result(s)
were classified as negative. Specimens with equivocal/
inconclusive results were excluded because their status
could not be categorized. Results from patients for whom
the testing laboratory did not provide the residential zip
code – essential to assigning race/ethnicity, income, and population density proportions – also were excluded.
Census estimates by zip code

To analyze race/ethnicity, patient zip code data were
linked to estimated race/ethnicity proportions in each corresponding zip code as reported by the 2018 5-year American Community Survey (ACS) on the US Census data
website (the most recent data available).11 The research
team used estimated proportions for single race, Black nonHispanic, Hispanic, White non-Hispanic, and Asian nonHispanic into categories of the same name. The team
grouped all other race/ethnicities, including multiple race/
ethnicities, into the ‘‘other’’ race/ethnicity categories. To
determine the proportion of testing that likely came from
each race/ethnicity group, the team weighted the result by
the race/ethnicity proportions within that zip code. For example, if a specimen came from a community with equal
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race/ethnicity proportions for the 5 categories, each would
be assigned a value of 0.2. These values were then summed
in the full analytic data set. To analyze income, mean
household income in the past 12 months (in 2018 inflationadjusted dollars) from 2018 ACS 5-Year Estimates was
used.12 Population density data came from the 2010
Census.13 The team analyzed positivity rates by quintiles of
race/ethnicity proportion, population density, and mean income to approximate the association with each of these
factors.
Statistical analyses

The research team controlled for various potentially
confounding factors, such as age, sex, income, and population density to better isolate the association of COVID-19
and minority communities, as determined by SARS-CoV-2
NAAT positivity rates. The chi-square test for proportions
and the t test for means were used to analyze differences between included and excluded patients. Trends in
COVID-19 positivity among race/ethnicity quintiles were
analyzed using the Cochran-Armitage test for trend. All
variables of interest (including statistically insignificant
variables) were included in the multivariable logistic regression model, given their potential as confounders. The
team separately included patient residence in the 5 states
with the highest confirmed COVID-19 rates per capita
(New York, New Jersey, Massachusetts, Rhode Island, and
Connecticut)14 as binary variables in the multivariable
model. Race/ethnicity proportions were included as continuous variables. Data analyses were performed using SAS
Studio 3.6 on SAS 9.4 (SAS Institute Inc., Cary, NC, USA).
This Quest Diagnostics Health Trends study was deemed
exempt by the Western Institutional Review Board (Puyallup,
Washington).
Results

The potential cohort included 3,134,778 SARS-CoV-2
molecular specimens from 2,935,158 unique patients
representing all 50 states and the District of Columbia. Patients without valid residential zip code data (n = 600,472)
were excluded followed by those with equivocal/inconclusive
results (n = 3511). The final analytic cohort (N = 2,331,175)
constituted 79.4% of potential patients for whom definitive
SARS-CoV-2 NAAT were obtained. Included patients were
younger, on average, than excluded patients (45.8 standard
deviation [SD] 18.5 vs. 46.3 SD 18.1, P < 0.0001) and more
likely to be female (56.5%, 95% confidence interval [CI]
56.5–56.5%, vs 55.7%, 95% CI 55.6–55.8%, P < 0.0001).
The SARS-CoV-2 NAAT positivity rate was higher for the
included population than the excluded population (11.6%,
95% CI 11.6–11.7%, vs 11.4%, 95% CI 11.3–11.5%,
P < 0.0001). The study population was 12.4% Black nonHispanic, 22.1% Hispanic, 56.1% White non-Hispanic, 5.9%
Asian non-Hispanic, and 3.5% ‘‘other’’ race/ethnicities.
These proportions are very close to American Community
Survey 2018 estimates for the national population (12.3%
Black non-Hispanic, 18.3% Hispanic, 60.2% White nonHispanic, 5.6% Asian non-Hispanic, and 3.6% for all other
ethnicities).15
There was a statistically significant increasing trend in
SARS-CoV-2 NAAT positivity for Black non-Hispanic
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FIG. 1. COVID-19 positivity by race/ethnicity community quintiles. Quintiles were derived from analysis of race/
ethnicity proportions as estimated by the US Census Bureau (2018 American Community Survey 5-Year Estimates).
Cochran-Armitage test for trend, P < 0.0001 for each race/ethnicity group.
quintiles (from 7.8% to 17.2%, P < 0.0001), Hispanic quintiles (from 8.4% to 15.5%, P < 0.0001), and Asian nonHispanic quintiles (from 9.6% to 13.4%, P < 0.0001) during
the time period of March 9 through May 31, 2020. There was
a statistically significant decreasing trend in SARS-CoV-2
NAAT positivity for White non-Hispanic quintiles (from
17.4% to 7.1%, P < 0.0001) and ‘‘other’’ race/ethnicity
quintiles (from 13.2% to 8.9%, P < 0.0001) (Figure 1).
Progressive quintiles of population density also demonstrated a statistically significant increasing trend (P < 0.0001)

in SARS-CoV-2 NAAT positivity rates (quintile 1, 6.8%;
quintile 2, 8.4%; quintile 3, 10.8%; quintile 4, 12.3%;
quintile 5, 19.8%). Positivity rates were analyzed for race/
ethnicity quintiles in the most densely populated areas
(quintile 5 of population density) and the least densely
populated areas (quintile 1 of population density) (Figure 2).
Statistically significant increasing trends in positivity for
the Black non-Hispanic and Hispanic populations were
demonstrated in both the most densely populated areas
(P < 0.0001 for all) and in the least densely populated areas
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FIG. 2. COVID-19 positivity by race/ethnicity community quintiles in the most and least densely populated areas.
Quintiles were derived from analysis of race/ethnicity proportions as estimated for each zip code by the US Census Bureau
(2018 American Community Survey 5-Year Estimates). Population density quintiles were derived from analysis of each zip
code by the US Census Bureau (2010 Census). Cochran-Armitage test for trend, P < 0.0001 for all groups except Asian nonHispanic in least densely populated areas (not significant).
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(P < 0.0001 for all). Statistically significant decreasing
trends in positivity for the White non-Hispanic population
and the ‘‘other’’ race/ethnicity populations were demonstrated in the most and least densely populated areas (P < 0.0001
for both). Statistically significant decreasing trends in positivity for the Asian non-Hispanic population were demonstrated in the most densely populated areas (P < 0.0001) but
there was no significant trend in the least densely populated
areas.
Progressive quintiles of mean income demonstrated a small
but statistically significant decreasing trend (P < 0.0001) in
SARS-CoV-2 NAAT positivity rates (quintile 1, 12.7%;
quintile 2, 10.9%; quintile 3, 12.1%; quintile 4, 11.5%; quintile 5, 11.0%). Positivity rates for race/ethnicity quintiles in
the highest income quintile and lowest income quintile were
analyzed (Figure 3). Statistically significant increasing trends
in positivity for the Black non-Hispanic, Hispanic, and Asian
non-Hispanic populations were demonstrated in both the
highest and lowest income areas (P < 0.0001 for all). Statistically significant decreasing trends in positivity for the White
non-Hispanic population and the ‘‘other’’ race/ethnicity
populations were demonstrated in both the highest and lowest
income areas (P < 0.0001 for all). In virtually every case, the
race/ethnicity quintile differences were considerably larger
in the lowest income quintile than they were in the highest
income quintile.
The increases in positivity associated with increases in
proportions of Black non-Hispanic and Hispanic populations
also are demonstrated in multivariable models (Table 1).
The model indicates significant increased risk of SARSCoV-2 NAAT positivity for males, and patients from individual states (New York, New Jersey, Connecticut, and
Massachusetts). There was a stepwise relationship between
progressive population density quintiles and SARS-CoV-2
NAAT positivity and a smaller, but also stepwise relation-
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ship between progressive income quintiles and SARS-CoV2 NAAT positivity. The association between SARS-CoV-2
NAAT positivity and increases in proportion of the Asian
non-Hispanic population changed from being strongly predictive in the unadjusted model (unadjusted odds ratio 4.61,
95% CI 4.40–4.83) to slightly protective in the adjusted
model (adjusted odds ratio 0.94, 95% CI 0.89–0.99).
Discussion

These findings on a national basis suggest that COVID-19
has disproportionately affected Black non-Hispanic communities, consistent in scope with previous analyses of
confirmed positive cases and mortality.1–6 The results indicate that Hispanic communities have been disproportionately affected as well, a subject that has not been thoroughly
researched previously. In both populations, these results are
indicated even in a multivariable model controlling for
known risk factors such as sex, the hardest hit individual
states, and population density.
Study data suggest that Black non-Hispanic and Hispanic
communities are representative among all patients tested for
SARS-CoV-2 RNA. The reasons for increased SARS-CoV2 positivity rates in Black non-Hispanic and Hispanic
communities tested are likely as complex as the communities themselves; however, population health experts have
proposed several situations that could be causing these
disparities. Ethnic minorities are overrepresented in essential jobs in industries including transportation, government,
health care, and food supply services, which may increase
their chances of being infected while at work.16 Previous
research also has shown higher rates of diseases such as
diabetes, heart disease,17 and obesity18 in African Americans, all of which have been linked to COVID-19 mortality,19 although the impact of these conditions on infection

FIG. 3. COVID-19 positivity by race/ethnicity community quintiles in the highest and lowest income areas. Quintiles
were derived from analysis of race/ethnicity proportions and mean income as estimated for each zip code by the US Census
Bureau (2018 American Community Survey 5-Year Estimates). Cochran-Armitage test for trend, P < 0.0001 for all groups.
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Table 1. Factors Associated with COVID-19 Positivity
Factors
Race/ethnicity proportions
Black non-Hispanic
Hispanic
Asian non-Hispanic
‘‘Other’’ race/ethnicity
White non-Hispanic
Age

Unadjusted odds ratio
(95% Wald confidence limits)
5.34
3.10
4.61
1.00

(5.24–5.45)
(3.05–3.15)
(4.40–4.83)
(1.00–1.00)
reference

Adjusted odds ratio
(95% Wald confidence limits)
4.60
3.06
0.94
1.18

(4.48–4.72)
(2.99–3.13)
(0.89–0.99)
(1.07–1.30)
reference

0.997 (0.996–0.997)

0.998 (0.998–0.998)

1.22 (1.21–1.23)
reference

1.23 (1.22–1.24)
reference

Population Density
Quintile 5 (highest density)
Quintile 4
Quintile 3
Quintile 2
Quintile 1 (lowest density)

3.37
1.91
1.64
1.25

(3.32–3.41)
(1.89–1.94)
(1.62–1.67)
(1.23–1.27)
reference

1.61
1.35
1.21
1.01

(1.59–1.64)
(1.33–1.38)
(1.19–1.23)
(1.00–1.03)
reference

Mean Income
Quintile 5 (highest income)
Quintile 4
Quintile 3
Quintile 2
Quintile 1 (lowest income)

0.85
0.89
0.94
0.84

(0.84–0.86)
(0.88–0.90)
(0.93–0.95)
(0.83–0.85)
reference

1.23
1.23
1.16
1.07

(1.21–1.25)
(1.21–1.24)
(1.14–1.18)
(1.06–1.09)
reference

Patient State
New York
New Jersey
Connecticut
Massachusetts
Rhode Island
All Others

2.81
3.02
1.72
1.83
0.83

(2.77–2.84)
(2.97–3.06)
(1.68–1.75)
(1.80–1.85)
(0.75–0.91)
reference

2.45
2.63
1.79
2.02
1.01

(2.41–2.48)
(2.59–2.68)
(1.75–1.83)
(1.99–2.05)
(0.92–1.11)
reference

Sex
Male
Female

Multivariable model included 2,261,456 of 2,331,175 (97.1%) of the study population with no missing data for any variables included in
the model. Odds ratios for race/ethnicity proportions should be interpreted using the following example; a 1% increase in the Black nonHispanic proportion within a zip code corresponds to the odds of testing positive for SARS-CoV-2 increasing by a factor of 4.6.

rates has not yet been fully explored.20–22 In contrast,
studies demonstrated that among people ages 65 years and
older, African American and Latino compared to White
people have lower mortality from influenza and pneumonia
as causes of death.17,23
Public health experts also have suggested that many risk
factors for COVID-19 are connected in part to socioeconomic status, collectively referred to as social determinants
of health, including reliance on public transportation for
those who cannot afford a car, living in densely populated
areas, having jobs without paid sick leave, disparities in
access to quality health care, and living in smaller multifamily (or multigenerational) homes that make social distancing inconvenient or even impossible.24 The cumulative
impact of social inequities from an early age may influence
racial and ethnic disparities in both clinical and subclinical health conditions.25 Although the research team agrees
with these factors in theory, data presented in this study
demonstrated higher rates of SARS-CoV-2 positivity in
higher income communities, after controlling for other
factors in multivariable models. This was unexpected, especially given the small but significant association of higher

income quintiles with lower SARS-CoV-2 positivity rates in
unadjusted analysis. One possible explanation is that a disproportionate number of employed health care workers are
being tested for SARS-CoV-2. While there is a wide range
of incomes among health care workers, some, notably
physicians, have higher incomes and high exposure frequency to infected patients. Moreover, COVID-19 positivity
rate disparities by race/ethnicity (particularly for the Black
non-Hispanic community) remained even within the highest
income communities, suggesting that lower income may not
play as large a role as previously assumed. It is also important to keep in mind that the income variable used was
based on the mean income for a patient’s zip code. The
relationship between patient income and COVID-19 positivity within zip codes, unfortunately, could not be analyzed
for this study. Inclusion of these additional covariates may
have yielded different results.
Other results from the multivariable models were interesting as well. To the research team’s knowledge, this is the
first study to examine SARS-CoV-2 molecular positivity
rates by population density quintiles. Unsurprisingly, higher
population density rates were associated with higher
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positivity rates, but the strength and stepwise nature of this
association were remarkable. Although more females than
males are tested, male patients were more likely to test positive than female patients, consistent with previous literature
showing that male patients are associated with increased
SARS-CoV-2 NAAT positivity,26 increased hospitalization
rates,26 and mortality.27 Four of the 5 states with the highest
per capita confirmed positivity rates nationally also were
strongly associated with positivity in this study, though residence in Rhode Island was not significantly associated with
positivity in the adjusted multivariable model.
Limitations and strengths

A clear limitation of this study is that there were no direct
patient ethnicity data, and the estimates are based on aggregate US Census race/ethnicity proportions by zip code. Other
related limitations include that patients may not be tested at
the same race/ethnicity mix within each zip code, some patients may reside in one zip code but became infected
somewhere else, and that, historically, hospitals have been
less likely to provide patient zip code information than other
facility types. Further, testing was based on specimens submitted to Quest Diagnostics only; other testing sites and
laboratories may have tested a different proportion of patients
within each zip code. However, analysis of test share indicated the population being tested for COVID-19 by Quest
Diagnostics appears to largely reflect the overall United
States regarding race/ethnicity proportions, at least when
analyzed by zip code. COVID-19 testing is typically not
random. People with symptoms or high exposure risk (eg,
health care workers) are theoretically more likely to be tested.
Yet some random testing is occurring as well, such as instances of preoperation screening. The mix of these factors,
and how they have changed over the time interval evaluated
in this study, is unknown. Further, these results reflect the
early months of COVID-19 in the United States. Data from
later time periods may show different associations. Strengths
included the large analytic cohort, which included patients
from all 50 states and the District of Columbia, and the
number of factors controlled for in multivariable models,
which allowed for better isolation of the impact COVID-19
has had on racial and ethnic minority communities.
Conclusions

Communities with the highest proportions of Black non-Hispanic and Hispanic populations have the highest SARSCov-2 molecular positivity rates, falling in line with previous
findings on confirmed COVID-19 cases and mortality.
However, this study demonstrated that these higher rates exist
even after controlling for many other potentially significant
risk factors, including population density and income. Although, clearly, more epidemiological research is needed, the
strength of these associations suggests that more efforts urgently need to be made to help mitigate the increased impact
of COVID-19 and, more broadly, the health disparities affecting both African Americans and Hispanics.28
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